Gravar-mail: SCDT-13. PHASE I CLINICAL TRIAL ON SYSTEMIC PD-1 BLOCKADE IN COMBINATION WITH DIRECT INTRA-TUMORAL INJECTION OF CTLA-4/PD-1 IMMUNE CHECKPOINT INHIBITION FOLLOWING RESECTION OF RECURRENT GLIOBLASTOMA